IRIS
MISSO, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.724
NA - Nord America 2.763
AS - Asia 2.103
SA - Sud America 321
AF - Africa 30
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.947
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.847
US - Stati Uniti d'America 2.739
SG - Singapore 709
IE - Irlanda 554
CN - Cina 493
IT - Italia 421
BR - Brasile 282
HK - Hong Kong 265
DE - Germania 213
GB - Regno Unito 203
UA - Ucraina 186
VN - Vietnam 185
KR - Corea 148
JP - Giappone 97
FI - Finlandia 72
FR - Francia 57
GR - Grecia 56
IN - India 55
TR - Turchia 52
SE - Svezia 31
PK - Pakistan 25
AT - Austria 17
BE - Belgio 15
CO - Colombia 11
CZ - Repubblica Ceca 11
ID - Indonesia 11
IR - Iran 11
AR - Argentina 10
CA - Canada 10
ZA - Sudafrica 9
ES - Italia 8
IQ - Iraq 8
NL - Olanda 8
PL - Polonia 8
BD - Bangladesh 7
EC - Ecuador 6
MA - Marocco 6
UZ - Uzbekistan 6
MX - Messico 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
IL - Israele 4
PY - Paraguay 4
TW - Taiwan 4
CL - Cile 3
CR - Costa Rica 3
KE - Kenya 3
SA - Arabia Saudita 3
SC - Seychelles 3
TN - Tunisia 3
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
LT - Lituania 2
MD - Moldavia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MG - Madagascar 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UY - Uruguay 1
VE - Venezuela 1
Totale 10.947
Salva come PNG Salva come JPEG
Città #
Moscow 1.387
Dallas 563
Dublin 554
Singapore 335
Santa Clara 318
Chandler 308
Jacksonville 300
Hong Kong 264
Seoul 145
Ashburn 125
Beijing 90
Hefei 82
Ann Arbor 81
New York 78
Dong Ket 72
Princeton 69
Medford 61
Bremen 60
Naples 58
Roxbury 53
Boardman 51
Ho Chi Minh City 48
Caserta 42
Bengaluru 40
Aversa 37
Woodbridge 36
Munich 29
Wilmington 29
Des Moines 24
São Paulo 24
Los Angeles 23
The Dalles 23
San Mateo 20
Napoli 19
Nuremberg 19
Hanoi 17
Brussels 15
Helsinki 15
Milan 15
Mountain View 15
Falkenstein 14
Brno 11
Cambridge 11
San Nicola la Strada 10
Rio de Janeiro 9
Rome 9
Tianjin 9
Vienna 9
Zhengzhou 9
Bahawalpur 8
Brasília 8
Council Bluffs 8
Falls Church 8
Istanbul 8
London 8
San Francisco 8
Warsaw 8
Cava Dei Tirreni 7
Düsseldorf 7
Belo Horizonte 6
Boston 6
Frankfurt am Main 6
Guangzhou 6
Johannesburg 6
Lappeenranta 6
Nanjing 6
Piscataway 6
Viterbo 6
Auburn Hills 5
Avellino 5
Biên Hòa 5
Brooklyn 5
Curitiba 5
Da Nang 5
Haiphong 5
Houston 5
Jakarta 5
Shenzhen 5
Changsha 4
Chicago 4
Ercolano 4
Fortaleza 4
Goiânia 4
Guarulhos 4
Gunzenhausen 4
Hangzhou 4
Newark 4
Norwalk 4
Paris 4
Roubaix 4
Salvador 4
San Jose 4
Secaucus 4
Shanghai 4
Taipei 4
Tashkent 4
Afragola 3
Amsterdam 3
Anápolis 3
Bascape 3
Totale 5.901
Salva come PNG Salva come JPEG
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 223
Mitochondria as playmakers of apoptosis, autophagy and senescence 181
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 179
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 174
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 171
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 162
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 162
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 162
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 157
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 156
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 154
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 153
Gene interference strategies as a new tool for the treatment of prostate cancer 151
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 149
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 149
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 148
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 147
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 146
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 146
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 145
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 144
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 142
Immune cell infiltration and inflammatory landscape in primary brain tumours 138
Bisphosphonates and cancer: what opportunities from nanotechnology? 138
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 137
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 136
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 136
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 134
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 134
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 131
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 129
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 128
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 128
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 127
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 126
Emerging pathways as individualized therapeutic target of multiple myeloma. 125
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 125
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 125
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 122
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 122
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 121
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 121
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 120
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 120
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 119
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 118
Flexible 3D nanofiber-based SERS biosensor for detection of miRNA-223-3p in early Laryngeal Cancer diagnosis 118
Tumour-specific uptake of anti-cancer drugs: the future is here. 118
Nanoparticelle e loro usi 115
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 114
Optimal Management of Prostate Cancer Based on its Natural Clinical History 114
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 114
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 112
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 112
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 111
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 109
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 109
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 109
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 108
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 108
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 108
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 107
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 106
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 106
Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study 105
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 105
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 105
Measurement of autophagy by flow cytometry 104
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 104
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 104
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 103
Mir-34: a new weapon against cancer? 103
Role of perineural invasion as a prognostic factor in laryngeal cancer 103
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 101
Lipid Nanoparticles to Deliver miRNA in Cancer 100
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 100
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 100
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 97
Hepatocarcinoma: genetic and epigenetic features 97
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 92
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 89
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 88
Non-coding RNAs as a new dawn in tumor diagnosis 88
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 84
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 83
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 82
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 82
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 79
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 79
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 77
Complex genetic landscape in CLL: Clinical impact on patients’ survival and insights into the altered molecular pathways 68
Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC 64
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction 57
Totale 11.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021336 0 0 0 0 0 13 64 47 29 42 61 80
2021/2022444 23 12 1 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/20251.464 27 31 6 85 232 195 209 119 226 117 123 94
2025/20265.999 280 388 859 281 568 3.623 0 0 0 0 0 0
Totale 11.202